Why is Aristo Bio-Tech falling/rising?

As of 18-Jul, Aristo Bio-Tech & Lifescience Ltd's stock price is currently at 124.05, reflecting a decrease of 0.95, or 0.76%. The stock has underperformed its sector today by 0.56%, and its delivery volume has significantly declined by 44.44% compared to the 5-day average, indicating falling investor participation. In terms of returns, the stock has shown a 5.26% increase over the past month, but it has a year-to-date decline of 6.73%. The stock is currently trading higher than its 100-day moving average but lower than its 5-day, 20-day, 50-day, and 200-day moving averages, suggesting mixed performance trends. There is no information available regarding positive or negative factors that could further explain the stock's recent movement.
Broader market context shows that over the past week, Aristo Bio-Tech has underperformed the Sensex, which has only declined by 0.72%, while the stock itself has dropped by 5.31%. However, on a yearly basis, the stock has outperformed the benchmark with a return of 29.22% compared to the Sensex's 0.68%. This indicates that while the stock is facing short-term challenges, it has had a strong performance over the longer term. The liquidity of the stock remains adequate for trading, as it is based on 2% of the 5-day average traded value.